1991
DOI: 10.1016/0014-2999(91)90065-x
|View full text |Cite
|
Sign up to set email alerts
|

Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
37
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 98 publications
(39 citation statements)
references
References 24 publications
2
37
0
Order By: Relevance
“…These down-to upstate transitions require channels that can be regulated by striatal transmitters acting through GPCRs, such as the interacting A 2A and D 2 receptors in the GABAergic enkephalinergic neurons. In a re- These effects on neurotransmitter release and neuronal excitability are paralleled by effects on motor activity and other behavioral responses, where selective A 2A receptor agonists or antagonists respectively counteract or potentiate the motor activation induced by dopamine D 2 receptor agonists [38][39][40][41][42]. Consequently, we predicted 15 years ago that A 2A receptor antagonists could be useful in Parkinson's disease, especially potentiating the effects of L-dopa or D 2 receptor agonists [43].…”
Section: The Antagonistic a 2a -D 2 Intramembrane Recep-tor Interactionmentioning
confidence: 99%
“…These down-to upstate transitions require channels that can be regulated by striatal transmitters acting through GPCRs, such as the interacting A 2A and D 2 receptors in the GABAergic enkephalinergic neurons. In a re- These effects on neurotransmitter release and neuronal excitability are paralleled by effects on motor activity and other behavioral responses, where selective A 2A receptor agonists or antagonists respectively counteract or potentiate the motor activation induced by dopamine D 2 receptor agonists [38][39][40][41][42]. Consequently, we predicted 15 years ago that A 2A receptor antagonists could be useful in Parkinson's disease, especially potentiating the effects of L-dopa or D 2 receptor agonists [43].…”
Section: The Antagonistic a 2a -D 2 Intramembrane Recep-tor Interactionmentioning
confidence: 99%
“…Indeed, the formation of heterodimers between these two receptors has been demonstrated (Canals et al, 2003). Adenosine A 2A receptor activation has been shown to modulate negatively the postsynaptic effects of dopamine at the biochemical, cellular, functional, and behavioral levels (Ferre et al, 1993(Ferre et al, , 1991a. Behaviorally, adenosine A 2A agonists produce dopamine D 2 -like antagonist effects and vice versa (Ferre et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…The basis for this reciprocal influence are attributed to the negative interaction between dopamine D 1 and D 2 receptors and adenosine A 1 and A 2A receptors that are blocked by caffeine (Ferré et al, 1997;Fredholm et al, 1999). Caffeine and theophylline acutely potentiate the motor-activating effects induced by dopamine receptor agonists (Ferré et al, 1991;Fredholm et al, 1983;Garrett and Griffiths, 1997;Kuribara, 1994;Misra et al, 1986) and reverse catalepsy induced by dopamine receptor antagonists (Hauber et al, 2001;Malec, 1997;Mandhane et al, 1997), whereas sensitization or upregulation of dopamine receptors sensitize rats to the motor-activating effect induced by caffeine or theophylline (Fenu et al, 2000;Fenu and Morelli, 1998;Ferré et al, 1994).…”
Section: Introductionmentioning
confidence: 99%